Gilead Sciences, Inc. (BMV:GILD)

DFS Statistics

Total Valuation

Gilead Sciences has a market cap or net worth of MXN 2.75 trillion. The enterprise value is 3.06 trillion.

Market Cap	2.75T
Enterprise Value	3.06T

Important Dates

The last earnings date was Friday, August 1, 2025.

Earnings Date	Aug 1, 2025
Ex-Dividend Date	Jun 13, 2025

Share Statistics

Current Share Class	1.24B
Shares Outstanding	n/a
Shares Change (YoY)	+0.28%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	1.24B

Valuation Ratios

The trailing PE ratio is 23.07 and the forward PE ratio is 14.02.

PE Ratio	23.07
Forward PE	14.02
PS Ratio	5.05
PB Ratio	7.43
P/TBV Ratio	n/a
P/FCF Ratio	15.54
P/OCF Ratio	14.76
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 11.82, with an EV/FCF ratio of 17.31.

EV / Earnings	25.70
EV / Sales	5.72
EV / EBITDA	11.82
EV / EBIT	14.96
EV / FCF	17.31

Financial Position

The company has a current ratio of 1.32, with a Debt / Equity ratio of 1.27.

Current Ratio	1.32
Quick Ratio	0.97
Debt / Equity	1.27
Debt / EBITDA	1.79
Debt / FCF	2.66
Interest Coverage	11.04

Financial Efficiency

Return on equity (ROE) is 33.40% and return on invested capital (ROIC) is 16.02%.

Return on Equity (ROE)	33.40%
Return on Assets (ROA)	12.62%
Return on Invested Capital (ROIC)	16.02%
Return on Capital Employed (ROCE)	24.77%
Revenue Per Employee	30.93M
Profits Per Employee	6.76M
Employee Count	17,600
Asset Turnover	0.53
Inventory Turnover	3.22

Taxes

In the past 12 months, Gilead Sciences has paid 16.78 billion in taxes.

Income Tax	16.78B
Effective Tax Rate	12.36%

Stock Price Statistics

The stock price has increased by +52.88% in the last 52 weeks. The beta is 0.35, so Gilead Sciences's price volatility has been lower than the market average.

Beta (5Y)	0.35
52-Week Price Change	+52.88%
50-Day Moving Average	2,099.76
200-Day Moving Average	2,024.50
Relative Strength Index (RSI)	81.17
Average Volume (20 Days)	713

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.96

Income Statement

In the last 12 months, Gilead Sciences had revenue of MXN 544.30 billion and earned 119.01 billion in profits. Earnings per share was 94.50.

Revenue	544.30B
Gross Profit	427.46B
Operating Income	208.02B
Pretax Income	135.80B
Net Income	119.01B
EBITDA	260.26B
EBIT	208.02B
Earnings Per Share (EPS)	94.50

Balance Sheet

The company has 114.24 billion in cash and 470.44 billion in debt, giving a net cash position of -320.12 billion.

Cash & Cash Equivalents	114.24B
Total Debt	470.44B
Net Cash	-320.12B
Net Cash Per Share	n/a
Equity (Book Value)	369.43B
Book Value Per Share	298.72
Working Capital	66.55B

Cash Flow

In the last 12 months, operating cash flow was 186.09 billion and capital expenditures -9.41 billion, giving a free cash flow of 176.68 billion.

Operating Cash Flow	186.09B
Capital Expenditures	-9.41B
Free Cash Flow	176.68B
FCF Per Share	n/a

Margins

Gross margin is 78.53%, with operating and profit margins of 38.22% and 21.87%.

Gross Margin	78.53%
Operating Margin	38.22%
Pretax Margin	24.95%
Profit Margin	21.87%
EBITDA Margin	47.82%
EBIT Margin	38.22%
FCF Margin	32.46%

Dividends & Yields

This stock pays an annual dividend of 61.48, which amounts to a dividend yield of 2.89%.

Dividend Per Share	61.48
Dividend Yield	2.89%
Dividend Growth (YoY)	15.86%
Years of Dividend Growth	1
Payout Ratio	62.75%
Buyback Yield	-0.28%
Shareholder Yield	2.61%
Earnings Yield	4.33%
FCF Yield	6.43%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on January 28, 2013. It was a forward split with a ratio of 2.

Last Split Date	Jan 28, 2013
Split Type	Forward
Split Ratio	2

Scores

Gilead Sciences has an Altman Z-Score of 3.47 and a Piotroski F-Score of 7.

Altman Z-Score	3.47
Piotroski F-Score	7